Advisors Asset Management Inc. lowered its holdings in shares of Clorox Co (NYSE:CLX) by 1.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,793 shares of the company’s stock after selling 639 shares during the quarter. Advisors Asset Management Inc.’s holdings in Clorox were worth $5,189,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Whittier Trust Co. of Nevada Inc. grew its holdings in shares of Clorox by 67.0% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 172 shares of the company’s stock worth $26,000 after buying an additional 69 shares in the last quarter. Savior LLC bought a new position in shares of Clorox during the fourth quarter worth about $31,000. Advisory Alpha LLC grew its holdings in shares of Clorox by 2,122.2% during the fourth quarter. Advisory Alpha LLC now owns 200 shares of the company’s stock worth $31,000 after buying an additional 191 shares in the last quarter. Pacitti Group Inc. bought a new position in shares of Clorox during the fourth quarter worth about $50,000. Finally, TI Trust Inc. bought a new position in shares of Clorox during the fourth quarter worth about $54,000. 80.04% of the stock is currently owned by institutional investors.
In other news, CEO Benno O. Dorer sold 252,794 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $169.01, for a total value of $42,724,713.94. Following the completion of the sale, the chief executive officer now directly owns 306,908 shares of the company’s stock, valued at $51,870,521.08. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Denise Garner sold 870 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $170.00, for a total value of $147,900.00. Following the completion of the sale, the senior vice president now directly owns 50,489 shares of the company’s stock, valued at $8,583,130. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 255,750 shares of company stock valued at $43,218,097. Corporate insiders own 1.14% of the company’s stock.
CLX has been the subject of a number of research reports. Credit Suisse Group downgraded Clorox from an “outperform” rating to a “neutral” rating and increased their price objective for the stock from $169.00 to $172.00 in a report on Thursday, March 19th. UBS Group increased their price objective on Clorox from $135.00 to $152.00 and gave the stock a “sell” rating in a report on Monday, March 16th. Deutsche Bank increased their price objective on Clorox from $147.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, February 5th. Argus upgraded Clorox from a “hold” rating to a “buy” rating and set a $195.00 price objective for the company in a report on Monday, March 9th. Finally, JPMorgan Chase & Co. upgraded Clorox from an “underweight” rating to an “overweight” rating and increased their price objective for the stock from $153.00 to $185.00 in a report on Monday, March 16th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the stock. Clorox presently has an average rating of “Hold” and an average target price of $163.07.
CLX stock opened at $165.66 on Thursday. The company has a quick ratio of 0.52, a current ratio of 0.86 and a debt-to-equity ratio of 4.63. The business has a 50 day moving average price of $169.33 and a two-hundred day moving average price of $156.34. The company has a market cap of $21.28 billion, a price-to-earnings ratio of 26.01, a P/E/G ratio of 5.06 and a beta of 0.36. Clorox Co has a twelve month low of $144.12 and a twelve month high of $214.26.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $1.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.15. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.45 billion. Clorox had a return on equity of 133.50% and a net margin of 13.31%. The business’s revenue was down 1.6% compared to the same quarter last year. During the same period last year, the company earned $1.40 earnings per share. On average, equities research analysts anticipate that Clorox Co will post 6.42 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd will be paid a $1.06 dividend. The ex-dividend date of this dividend is Tuesday, April 21st. This represents a $4.24 dividend on an annualized basis and a yield of 2.56%. Clorox’s dividend payout ratio is 67.09%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Further Reading: Cash Asset Ratio
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.